Comparative efficacy of <i>Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus rhamnosus</i> composition and prucalopride in treatment of constipation variant of irritable bowel syndrome
Aim of investigation. To estimate effect of probiotics and enterokinetic agents on severity of clinical symptoms, presence of bacterial overgrowth syndrome (BOS) and quality of life of patients with constipation variant of irritable bowel syndrome (IBS-C).Material and methods. Comparative analysis o...
Saved in:
Main Authors: | V. T. Ivashkin, O. M. Drapkina, A. A. Sheptulin, O. S. Shifrin, Ye. A. Poluektova, S. Yu. Kuchumova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2015-07-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/1009 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative assessment of <i>Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus rhamnosus</i> and <i>Saccharomyces boulardii</i> efficacy at diarrheal variant of irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2015-05-01) -
Effects of <i>Bifidobacterium longum longum</i> 35624® on the Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome: Results of the Multicenter Observational Program SAGA
by: V. T. Ivashkin, et al.
Published: (2024-12-01) -
Effectiveness of Bifidobacterium longum 35624 in the treatment of patients with irritable bowel syndrome: a systematic review
by: D. Andreev, et al.
Published: (2024-06-01) -
Cell free supernatants of Bifidobacterium adolescentis and Bifidobacterium longum suppress the tumor growth in colorectal cancer organoid model
by: Min Jung Kim, et al.
Published: (2025-01-01) -
2′-Fucosyllactose as a prebiotic modulates the probiotic responses of Bifidobacterium bifidum
by: Jingfang Du, et al.
Published: (2025-01-01)